Harrow (HROW) Non-Current Deferred Tax Liability (2015 - 2020)
Harrow (HROW) posted Non-Current Deferred Tax Liability of $274000.0 for Q4 2020, up 1.48% on a QoQ basis from $270000.0 in Q4 2019, and up 1.48% year-over-year from $270000.0 in Q1 2020.
Analysis
Harrow (HROW) Non-Current Deferred Tax Liability (2015 - 2020) Analysis & Trends
Harrow has reported Non-Current Deferred Tax Liability for 5 years, with the latest figure at $274000.0 in Q4 2020.
- On a quarterly basis, Non-Current Deferred Tax Liability rose 1.48% year-over-year to $274000.0 in Q4 2020; TTM through Dec 2020 was $274000.0, a 1.48% increase from a year earlier, with the FY2020 full-year figure at $274000.0, up 1.48% from the prior year.
- Non-Current Deferred Tax Liability was $274000.0 for Q4 2020 at Harrow, up from $270000.0 in the prior quarter.
- The five-year high for Non-Current Deferred Tax Liability was $1.0 million in Q1 2016, with the low at $270000.0 in Q4 2019.
- Average Non-Current Deferred Tax Liability over 4 years is $806777.8, with a median of $908000.0 recorded in 2017.
- The sharpest annual moves came in 2017 and 2020: Non-Current Deferred Tax Liability decreased 18.62% in 2017, then rose 1.48% in 2020.
- Over 4 years, Non-Current Deferred Tax Liability stood at $936000.0 in 2016, then declined by 8.97% to $852000.0 in 2017, then slumped by 68.31% to $270000.0 in 2019, then grew by 1.48% to $274000.0 in 2020.
- The last three Non-Current Deferred Tax Liability figures came in at $274000.0 (Q4 2020), $270000.0 (Q4 2019), and $852000.0 (Q3 2017), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.88 Bn | 625.12 Bn | 17.26 Bn |
| 2 | AbbVie | 442.18 Bn | 435.61 Bn | 12.70 Bn |
| 3 | Merck | 366.59 Bn | 359.45 Bn | 12.21 Bn |
| 4 | Novartis Ag | 266.49 Bn | 258.80 Bn | 11.24 Bn |
| 5 | Pfizer | 159.09 Bn | 147.39 Bn | 10.94 Bn |
| 6 | Sanofi | 52.34 Bn | 44.96 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - |
| 8 | Incyte | 25.38 Bn | 20.85 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.53 Bn | 18.87 Bn | 683.80 Mn |
| 10 | Harrow | 1.40 Bn | 1.32 Bn | 50.36 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2020 | 274,000.00 |
| Dec 31, 2019 | 270,000.00 |
| Sep 30, 2017 | 852,000.00 |
| Jun 30, 2017 | 880,000.00 |
| Mar 31, 2017 | 908,000.00 |
| Dec 31, 2016 | 936,000.00 |
| Sep 30, 2016 | 1.05 Mn |
| Jun 30, 2016 | 1.05 Mn |
| Mar 31, 2016 | 1.05 Mn |
| Dec 31, 2015 | 1.05 Mn |